Yan Yin
Transaction: 10/30/2024
SELL
Change
-143,845
Price
$0.57
Filing
11/18/2024
Type
SELL
Bio Essence Corporation
BIOE • Drug Manufacturers - Specialty & Generic
$0.19
— 0.00 (0.00%)
Current price
EarningsLatest report: Mar 31, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$8.54M
Growth
1.1%
Cash Flow
2/5
Trend
Volatile
Evidence
Stable or improving margins · 47.2%Positive revenue growth · 16.7%Positive free cash flow · 0.04Reasonable earnings multiple · 2.54Weak liquidity · 0.17
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: Mar 31, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 1:10 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$0.19
Change0.00%
Shares Out44.95M
Market Cap$8.54M
Enterprise Value$10.07M
52W Range0.05 - 0.52
Beta6.14
P/E6.53
P/S3.59
P/B-5.98
P/FCF7.21
EV/Sales4.24
Price$0.19
Change0.00%
Shares Out44.95M
Market Cap$8.54M
Enterprise Value$10.07M
52W Range0.05 - 0.52
Beta6.14
P/E6.53
P/S3.59
P/B-5.98
P/FCF7.21
EV/Sales4.24
EV/EBITDA7.62
EV/FCF8.51
Earnings Yield15.31%
FCF Yield13.86%
Dividend Yield0.00%
Gross Margin75.28%
Oper. Margin47.43%
Profit Margin47.23%
Debt/Eq-0.75
Current Ratio0.17
Quick Ratio0.17
Revenue 5Y1.07%
Volume200.00
Avg Volume874.00
Investment DNA
How strong this company looks for long-term investors
76
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
45/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Stable or improving margins · 47.2%Positive revenue growth · 16.7%Positive free cash flow · 0.04Reasonable earnings multiple · 2.54Weak liquidity · 0.17
Analyst view
No analyst data available now.
Financial Health
Score9 / 20
Debt / Equity: -0.75
Current Ratio: 0.17
Quick Ratio: 0.17
Status: Moderate
Warnings
- Weak Liquidity
- Weak quick ratio
Insider Transactions
Recent executive and insider activity
⚠ 3 high-volume insider sells detected
Yan Yin
Transaction: 10/29/2024
SELL
Change
-40,000
Price
$0.64
Filing
11/18/2024
Type
SELL
Yan Yin
Transaction: 10/28/2024
SELL
Change
-140,000
Price
$2.48
Filing
11/18/2024
Type
SELL
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Yan Yin | SELL | -143,845 | $0.57 | 10/30/2024 | 11/18/2024 |
| Yan Yin | SELL | -40,000 | $0.64 | 10/29/2024 | 11/18/2024 |
| Yan Yin | SELL | -140,000 | $2.48 | 10/28/2024 | 11/18/2024 |
| Yan Yin | BUY | +5,000,000 | $0.50 | 06/06/2023 | 10/11/2024 |
| Yan Yin | SELL | -1,990 | $2.35 | 09/30/2024 | 10/10/2024 |
| Yan Yin | SELL | -200 | $1.69 | 09/27/2024 | 10/10/2024 |
| Yan Yin | SELL | -40,000 | $1.67 | 09/26/2024 | 10/10/2024 |
| Yan Yin | SELL | -50,000 | $0.70 | 09/25/2024 | 10/10/2024 |
| Yan Yin | SELL | -73,965 | $8.94 | 07/05/2024 | 10/10/2024 |
| Yan Yin | SELL | -100,000 | $8.78 | 07/03/2024 | 10/10/2024 |
| Yan Yin | SELL | -50,000 | $7.83 | 07/02/2024 | 10/10/2024 |
| Yan Yin | SELL | -6,209 | $9.07 | 07/05/2024 | 07/17/2024 |
| Yan Yin | SELL | -4,065 | $8.96 | 07/03/2024 | 07/17/2024 |
| Yan Yin | SELL | -50,000 | $7.83 | 07/02/2024 | 07/17/2024 |
| Yan Yin | BUY | +5,000,000 | $0.50 | 06/06/2023 | 06/03/2024 |
| Yan Yin | OTHER | 0 | Not reported | 12/08/2017 | 06/03/2024 |